Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Applied DNA Sciences Q1 2024 GAAP EPS $(0.09) Beats $(0.31) Estimate, Sales $891.16K Beat $776.00K Estimate

Author: Benzinga Newsdesk | February 08, 2024 05:38pm
Applied DNA Sciences (NASDAQ:APDN) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.31) by 70.97 percent. This is a 70 percent increase over losses of $(0.30) per share from the same period last year. The company reported quarterly sales of $891.16 thousand which beat the analyst consensus estimate of $776.00 thousand by 14.84 percent. This is a 83.07 percent decrease over sales of $5.26 million the same period last year.

Posted In: APDN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist